Trams Pharmaceuticals Private Limited
About Trams Pharmaceuticals Private Limited
Data last updated:
Trams Pharmaceuticals Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 10 February 2022.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24290PN2022PTC208494.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ashwini Balu Nakade and Manisha Mahesh Marne.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bld – B1 Gala1 Sec 20 Sch – 2 Krishna Ngr Chinchwad, Pune, Maharashtra, India – 411019.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.5 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹47,408 (net margin 7.3%) and EBITDA of ₹59,874 (EBITDA margin 9.2%).
Company details
Contact details
Trams Pharmaceuticals Private Limited's registered office is in Pune, Maharashtra.
- Registered AddressBld – B1 Gala1 Sec 20 Sch – 2 Krishna Ngr Chinchwad, Pune, Maharashtra, India – 411019
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Trams Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Trams Pharmaceuticals Private Limited, buy the company report.
Financials of Trams Pharmaceuticals Private Limited
FY 2025 filings availableTrams Pharmaceuticals Private Limited reported revenue of ₹6.5 Lakh (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year. EBITDA rose 679% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹59,874 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹47,408 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 9.2% | ||
| Net Profit Margin | 7.3% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Trams Pharmaceuticals Private Limited, buy the company report.
Board of directors of Trams Pharmaceuticals Private Limited
Trams Pharmaceuticals has 4 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwini Balu Nakade | Director | 10 Feb 2022 | 4 Years 8 Months | Current |
| Manisha Mahesh Marne | Director | 10 Feb 2022 | 4 Years 8 Months | Current |
| Sangeeta Deepak Lokhande | Director | 10 Feb 2022 | 4 Years 8 Months | Current |
| Reshma Vijay Lokhande | Director | 10 Feb 2022 | 4 Years 8 Months | Current |
Legal cases
No court or tribunal cases involving Trams Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Trams Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Trams Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Trams Pharmaceuticals Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Ashwini Balu Nakade was appointed as Director on 10 Feb 2022.
Frequently asked questions
Trams Pharmaceuticals is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 10 February 2022 (4+ years old) and is registered under CIN U24290PN2022PTC208494.
Trams Pharmaceuticals has 4 current directors:
- Ashwini Balu Nakade - Director
- Manisha Mahesh Marne - Director
- Sangeeta Deepak Lokhande - Director
- Reshma Vijay Lokhande - Director
The latest financial statements of Trams Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The CIN (Corporate Identification Number) of Trams Pharmaceuticals is U24290PN2022PTC208494. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Trams Pharmaceuticals was incorporated on 10 February 2022, making it 4+ years old. It is registered with the Registrar of Companies, Pune.
Ashwini Balu Nakade was appointed as Director on 10 Feb 2022. Manisha Mahesh Marne was appointed as Director on 10 Feb 2022. Reshma Vijay Lokhande was appointed as Director on 10 Feb 2022. Trams Pharmaceuticals has 4 board changes on record in total.
The registered office of Trams Pharmaceuticals is at Bld – B1 Gala1 Sec 20 Sch – 2 Krishna Ngr Chinchwad, Pune, Maharashtra, India – 411019.
Trams Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Trams Pharmaceuticals can be reached at its registered office: Bld – B1 Gala1 Sec 20 Sch – 2 Krishna Ngr Chinchwad, Pune, Maharashtra, India – 411019.
Trams Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Pune.